Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5883

REMS tweaks for Travere’s Filspari; AstraZeneca stops early-phase cardio study

$
0
0
Plus, news about Eli Lilly and Cognition Therapeutics: 🔎 FDA simplifies REMS for Travere’s kidney drug: The updated safety strategy for Travere’s Filspari recommends liver monitoring ...

Viewing all articles
Browse latest Browse all 5883

Trending Articles